НовостиBenzingaMorgan Stanley Initiates Coverage On Adarx Pharmaceuticals with Overweight Rating, Announces Price Target of $32 Morgan Stanley Initiates Coverage On Adarx Pharmaceuticals with Overweight Rating, Announces Price Target of $32 Benzinga 2026.10.20 09:54 (GMT+0) Открыть на Benzinga Другие новости